Alison Thornhill
Family · Bogalusa, LANPI 1528409612
Payments from drug & device makers
Across 182 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Calliditas Therapeutics US Inc.$477
- Otsuka America Pharmaceutical, Inc.$321
- Bayer$272
- Shield Therapeutics Inc$190
- Vifor Pharma, Inc.$156
- OPKO Pharmaceuticals, LLC$152
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,60999%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Calliditas Therapeutics US Inc. | 25 | $477 |
| Otsuka America Pharmaceutical, Inc. | 16 | $321 |
| Bayer | 15 | $272 |
| Shield Therapeutics Inc | 11 | $190 |
| Vifor Pharma, Inc. | 8 | $156 |
| OPKO Pharmaceuticals, LLC | 9 | $152 |
| Sanofi | 5 | $150 |
| Novo Nordisk | 4 | $149 |
| GSK | 9 | $145 |
| Boehringer Ingelheim | 8 | $139 |
| Fresenius USA Marketing, Inc. | 8 | $133 |
| ANI Pharmaceuticals, Inc. | 3 | $128 |
| Akebia Therapeutics Inc | 6 | $128 |
| Amgen(2 entities) | 6 | $126 |
| Novartis | 4 | $108 |
| Lilly USA, LLC | 6 | $101 |
| AstraZeneca | 5 | $98 |
| Aurinia Pharma U.S., Inc. | 5 | $97 |
| Mallinckrodt Hospital Products Inc. | 4 | $78 |
| Scpharmaceuticals Inc. | 4 | $73 |
| Axsome Therapeutics, Inc. | 2 | $64 |
| Gilead | 2 | $48 |
| Harmony Biosciences LLC | 2 | $44 |
| Viiv Healthcare Company | 1 | $35 |
| AbbVie | 1 | $28 |
| Corium, LLC | 1 | $27 |
| Organon | 2 | $24 |
| Alkermes, Inc. | 1 | $21 |
| Travere Therapeutics, Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $18 |
| Cormedix Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $6 |
How this compares
$3,654 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cinacalcet Hcl | 12 | $386 |
| Calcitriol | 23 | $317 |
| Hydralazine Hcl | 23 | $316 |
| Potassium Chloride | 17 | $249 |
| Atorvastatin Calcium | 18 | $191 |
| Metoprolol Succinate | 15 | $165 |
| Gabapentin | 11 | $137 |
| Levothyroxine Sodium | 11 | $124 |
| Amlodipine Besylate | 20 | $120 |
| Allopurinol | 19 | $117 |
| Lisinopril | 24 | $115 |
| Buspirone Hcl | 11 | $88 |
| Losartan Potassium | 13 | $73 |
Paid to pharmacies, not to this prescriber.
Other family in Bogalusa
- Amy SealeBogalusa$50K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.